vimarsana.com

Page 149 - புனே அடிப்படையிலானது சீரம் நிறுவனம் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Brazil Turns To India After Chinese Covid-19 Vaccine Candidates Run Into Major Credibility Crisis

Covid 19 vaccine rollout set to begin next week across India, says government | India News

Mission Vaccine: Controversy over Covishield name; notice issued to SII

Adar Poonawala India is all set to receive the 1st Covid-19 vaccine as the Drug Controller General of India (DCGI) on Sunday has approved Oxford AstraZeneca’s CoviShield and Bharat Biotech’s Covaxin for restricted use in India. India is gearing up to begin the biggest vaccination drive for one nation in history. However, controversy has arisen over the name of the Pune-based Serum Institue of India’s vaccine. A civil court in Pune issued a notice to SII on the application of a pharmaceutical company and vendor. This vaccine, prepared by Oxford University, has been named ‘Covishield’ but at the same time, Adar Poonawala’s company has received notice regarding the name of the vaccine. The notice requested the Serum Institute of India to stop using ‘Covishield’ trademarks or other similar names in its upcoming covid-19 vaccination. This has been filed by Maharashtra’s Nanded-based firm, Cutis-Biotech claiming that they had been using the ‘Kovishield’ trademark s

Nepal, India likely to ink Covid vaccine pact during Gyawali s visit to New Delhi

Nepal, India likely to ink Covid vaccine pact during Gyawali s visit to New Delhi Kathmandu Post Kathmandu/ New Delhi, Jan. 6 Minister for Foreign Affairs Pradeep Gyawali is all set to embark on his visit to New Delhi on January 14 to participate in the sixth meeting of the Nepal-India Joint Commission. The two neighbours have already started exchanging the texts of at least a couple of memoranda of understanding expected to be signed during the Nepali minister s trip to the Indian capital. As one of the MoUs is related to cooperation in the health sector, some officials believe this could entail an agreement on the procurement of Covid vaccines from India.

Coronavirus Vaccine: India A Step Closer To Covid Vaccine, Drug Regulator Approval Awaited: 10 Facts

India COVID Vaccine: India has logged over 1.3 crore cases of coronavirus so far. New Delhi: India has moved a step closer to getting a coronavirus vaccine as two candidates - Hyderabad-based Bharat Biotech s Covaxin and the Serum Institute of India s Covishield - have been recommended by a government-appointed panel to the Drugs Controller General of India (DCGI) for emergency use in the last two days. The country has been preparing for the vaccine rollout for the last four months, Health Minister Harsh Vardhan said on Saturday as he reviewed the dry run in Delhi. An end-to-end mock drill on the vaccine administration was conducted in all the states and union territories on Saturday, an exercise compared by the Health Minister to holding elections. DCGI chief Dr Venugopal G Somani is expected to share details about the vaccine candidates today at 11 AM.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.